Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states

Table 1 Cohort characteristics. There were no significant differences between group ages or CD4 counts within the HIV + patients

Group	Study ID	Age	Gender	HIV VL/mL	CD4 count
*EnKS*	21,147	39	Male	NA	NA
*EnKS*	21,182	57	Male	NA	NA
EpKS	21,117	38	Female	3450	130
EpKS	21,119	39	Male	ND	264
EpKS	21,120	56	Male	14,500	482
EpKS	21,121	42	Male	6310	30
EpKS	21,145	26	Male	NR	422
EpKS	21,161	38	Male	148,000	710
EpKS	21,204	58	Male	ND	261
EpKS	21,220	30	Female	NR	67
EpKS	21,228	38	Female	NR	333
KSHV + HIV −	21,525	48	Male	NA	256
KSHV + HIV −	21,526	50	Male	NA	310
KSHV + HIV −	21,527	54	Male	NA	931
KSHV + HIV −	21,528	55	Male	NA	303
KSHV + HIV −	21,559	33	Female	NA	1054
KSHV + HIV −	21,562	33	Female	NA	1398
KSHV + HIV +	21,570	36	Female	NR	500
KSHV + HIV +	21,575	34	Male	NR	675
KSHV + HIV +	21,578	38	Male	NR	316
KSHV + HIV +	21,579	43	Male	NR	240
KSHV + HIV +	21,580	48	Female	NR	295
KSHV + HIV +	21,582	34	Female	NR	594
KSHV + HIV +	21,583	35	Female	NR	124

ISSN: 2049-3002